In a seismic shift for AI-powered healthcare, Navina has clinched a staggering $55 million Series C funding round, supercharging its quest to redefine clinical intelligence. This latest infusion rockets the company’s total funding to a formidable $100 million, cementing its position as a vanguard in the field.
Fueling the Future of AI-Driven Healthcare
Navina, a New York-based artificial intelligence company specializing in clinical intelligence, announced on Tuesday that the funds will be channeled into advancing its proprietary AI technology. The goal? To become the gold standard in unified patient data, seamlessly enhancing both efficiency and care quality for healthcare providers and payers.
The company’s cutting-edge platform serves as a real-time co-pilot for clinicians, delivering precision-driven insights that elevate both patient outcomes and financial efficiency. Already entrenched in 1,300 clinics and trusted by over 10,000 healthcare professionals, Navina is rapidly reshaping the healthcare landscape.
